Janus Henderson Group’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Janus Henderson Group’s Portfolio EGRX Stock Details EGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-775,525	Closed	-$4.06M	–	2585
2023 Q4	$4.06M	Sell	775,525 -365,848	-32%	-$1.91M	﹤0.01%	907
2023 Q3	$18M	Sell	1,141,373 -6,398	-0.6%	-$101K	0.01%	556
2023 Q2	$22.3M	Sell	1,147,771 -658	-0.1%	-$12.8K	0.01%	540
2023 Q1	$32.6M	Sell	1,148,429 -81,443	-7%	-$2.31M	0.02%	472
2022 Q4	$35.9M	Sell	1,229,872 -1,249,686	-50%	-$36.5M	0.03%	447
2022 Q3	$65.5M	Buy	2,479,558 +1,042,244	+73%	+$27.5M	0.02%	455
2022 Q2	$63.9M	Sell	1,437,314 -48,090	-3%	-$2.14M	0.04%	329
2022 Q1	$73.5M	Sell	1,485,404 -42,748	-3%	-$2.12M	0.04%	400
2021 Q4	$77.8M	Buy	1,528,152 +1,050	+0.1%	+$53.5K	0.03%	417
2021 Q3	$85.2M	Sell	1,527,102 -3,375	-0.2%	-$188K	0.04%	393
2021 Q2	$65.5M	Sell	1,530,477 -60,233	-4%	-$2.58M	0.03%	498
2021 Q1	$66.4M	Sell	1,590,710 -103,363	-6%	-$4.31M	0.03%	472
2020 Q4	$78.9M	Sell	1,694,073 -4,664	-0.3%	-$217K	0.04%	424
2020 Q3	$72.2M	Sell	1,698,737 -7,907	-0.5%	-$336K	0.04%	404
2020 Q2	$81.9M	Sell	1,706,644 -52,850	-3%	-$2.54M	0.05%	362
2020 Q1	$80.9M	Sell	1,759,494 -40,215	-2%	-$1.85M	0.06%	326
2019 Q4	$108M	Buy	1,799,709 +33,909	+2%	+$2.04M	0.06%	345
2019 Q3	$99.9M	Sell	1,765,800 -2,354	-0.1%	-$133K	0.05%	368
2019 Q2	$98.5M	Sell	1,768,154 -5,098	-0.3%	-$284K	0.05%	377
2019 Q1	$89.5M	Sell	1,773,252 -22,210	-1%	-$1.12M	0.05%	410
2018 Q4	$72.3M	Sell	1,795,462 -86,039	-5%	-$3.47M	0.05%	439
2018 Q3	$130M	Sell	1,881,501 -9,797	-0.5%	-$679K	0.07%	329
2018 Q2	$143M	Sell	1,891,298 -15,062	-0.8%	-$1.14M	0.08%	293
2018 Q1	$100M	Buy	1,906,360 +245,479	+15%	+$12.9M	0.06%	372
2017 Q4	$88.7M	Sell	1,660,881 -146,321	-8%	-$7.82M	0.05%	396
2017 Q3	$108M	Sell	1,807,202 -22,997	-1%	-$1.37M	0.07%	347
2017 Q2	$144M	Buy	+1,830,199	New	+$144M	0.1%	264